Can ischemia-modified albumin help in differentiating myocardial perfusion scintigraphy results?

Ede, Huseyin; Yaylak, Baris; Akkaya, Suleyman; Karacavus, Seyhan; GÖÇMEN, AYŞE; Erbay, Ali

doi:10.5543/tkda.2016.99148

Can ischemia-modified albumin help in differentiating myocardial perfusion scintigraphy results?

Ede H., Yaylak B., Akkaya S., Karacavus S., GÖÇMEN A. Y., Erbay A. R.

TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, cilt.44, sa.5, ss.380-388, 2016 (ESCI, Scopus, TRDizin)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 44 Sayı: 5
Basım Tarihi: 2016
Doi Numarası: 10.5543/tkda.2016.99148
Dergi Adı: TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY
Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
Sayfa Sayıları: ss.380-388
Yozgat Bozok Üniversitesi Adresli: Evet

Özet

Objective: Myocardial perfusion scintigraphy (MPS) is a diagnostic tool commonly used to detect significant coronary lesion. However equivocal, false negative or positive results can be yielded. Controversial findings regarding the role of ischemia-modified albumin (IMA) in MPS evaluation persist. The aim of the present study was to examine the role of serum IMA in the assessment of MPS results.